Skip to main content
  1. Life
  2. Pets
  3. Cats

Novartis Animal Health to get new owner

See also

Swiss drug maker Novartis announced April 22 that it plans to sell its animal health division to another pharmaceutical firm, Indianapolis-based Eli Lilly and Co., so it can focus on other business areas.

Lilly said the acquisition would complement its existing animal health unit, Elanco. Novartis cat products include Capstar flea treatment and Onsior pain medicine, while Elanco makes Comfortis flea tablets.

“Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a robust pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees,” Lilly said. “Combining these two great companies will enable us to provide more diversified brands, reach more market segments, expand our global footprint, and strengthen our pipeline, capabilities and expertise.”

No changes to existing cat products are planned, said Elanco spokeswoman Colleen Parr Dekker.

If approved by regulators, the $5.4 billion deal is expected to take effect by the first quarter of 2015.

SUBSCRIBE! To receive future cat articles by this writer, click “Subscribe” above. Follow him on Facebook and Twitter.



  • Tom Petty
    Seven overlooked videos that prove the genius of Tom Petty and the Heartbreakers
    Today's Buzz
  • Gaylord Pickens
    Discover Gaylord-Pickens Oklahoma Heritage Museum dollar days
    6 Photos
  • Yoga poses
    Learn how to strengthen your core muscles with these yoga poses
    5 Photos
  • Baby boomer STD rates
    Sexually transmitted diseases: Baby boomers booming STD rates
    7 Photos
  • Open relationships
    Are you thinking about exercising your option to be in an open relationship?
    5 Photos
  • Medical symptoms
    See which symptoms should cause you to seek a doctor’s attention right away
    6 Photos